Study of the Week: Niemann-Pick Disease Type C Biomarker Could Help Diagnose Congenital Disorders of Glycosylation
source: pixabay.com

Study of the Week: Niemann-Pick Disease Type C Biomarker Could Help Diagnose Congenital Disorders of Glycosylation

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Niemann-Pick Disease Type C Biomarker Could Help Diagnose Congenital Disorders of Glycosylation
Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 2)
Dr. Katz

Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 2)

Don't forget to read Part 1 of our interview. In Part 1, we discussed what chronic granulomatous disease (CGD) is, how it is treated, and how parents and physicians can identify an…

Continue Reading Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 2)
Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 1)
Dr. Katz

Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 1)

For over three decades, Dr. Ben Katz and his research team have been treating patients with chronic granulomatous disease (CGD) and working to build a better understanding of the disease…

Continue Reading Advancing Research into Chronic Granulomatous Disease (CGD): An Interview with Dr. Katz (Pt. 1)
Chronic Granulomatous Disease: A Stem Cell Transplant Approach to Speed up the Wait List
source: pixabay.com

Chronic Granulomatous Disease: A Stem Cell Transplant Approach to Speed up the Wait List

  According to Dr. Deepak Chellapandian, a Johns Hopkins specialist in bone marrow transplant for rare diseases, the prognosis for his patient was very poor. Jocelyn was born with chronic…

Continue Reading Chronic Granulomatous Disease: A Stem Cell Transplant Approach to Speed up the Wait List
Chronic Granulomatous Disease: Acetaminophen Use can Trigger a False-Positive Diagnostic Test
source: pixabay.com

Chronic Granulomatous Disease: Acetaminophen Use can Trigger a False-Positive Diagnostic Test

According to a story from newshealth.biz, the results of recent research have revealed that recent use of acetaminophen can trigger a false-positive result on the dihydrorhodamine (DHR) test. This test…

Continue Reading Chronic Granulomatous Disease: Acetaminophen Use can Trigger a False-Positive Diagnostic Test
New Treatment for X-Linked Chronic Granulomatous Disease Granted Orphan Drug Designation
source: pixabay.com

New Treatment for X-Linked Chronic Granulomatous Disease Granted Orphan Drug Designation

Orchard Therapeutics is investigating their gene therapy, OTL-102, for the treatment of X-linked chronic granulomatous disease (X-CGD). This treatment has recently received the Orphan Drug designation from the FDA, which…

Continue Reading New Treatment for X-Linked Chronic Granulomatous Disease Granted Orphan Drug Designation
New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future
source: pixabay.com

New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future

According to a story from Newswise, a team of scientists and researchers associated with Université de Montréal and CHU Sainte-Justine have recently completed a study that maps a cellular model…

Continue Reading New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future

Proof-of-Concept Trial for X-Linked Chronic Granulomatous Disease Treatment Shows Promise

According to a story from Markets Insider, the biopharmaceutical company Orchard Therapeutics recently announced the presentation of proof-of-concept data in regards to their investigational drug candidate OTL-102. This experimental therapy…

Continue Reading Proof-of-Concept Trial for X-Linked Chronic Granulomatous Disease Treatment Shows Promise

CGD News: Genetic Code Editing Makes Animal Testing More Accurate

There is a long-standing debate on the ethical ramifications of testing medical procedures and drug treatments on animals. One side argues that nothing can replace the valuable information gathered from…

Continue Reading CGD News: Genetic Code Editing Makes Animal Testing More Accurate

Editor’s Choice: IDF Sessions on CGD, IPF Progress and FDA Approval

Happy Friday Patient Worthians! You might notice that the headline has a lot of acronyms in it... ah, welcome to the rare disease world! We DO have answers for what all of that…

Continue Reading Editor’s Choice: IDF Sessions on CGD, IPF Progress and FDA Approval